Company profile: Aktana
1.1 - Company Overview
Company description
- Provider of AI-driven solutions for life science companies to optimize HCP engagement and commercial execution, including HCP Engagement AI, Next Best Action solutions, Field and Omnichannel Orchestrators, Data Readiness Assessment, and Aktana for MedTech. Supports more than 100 brands.
Products and services
- Next Best Action (NBA) solutions: AI-driven, these assemblies drive proactive business intelligence into commercial execution, architecting recommendations that optimize HCP engagement with prescribing physicians across sales and marketing workflows
- HCP Engagement AI: Omnichannel, this product personalizes HCP engagement by calibrating channel mix, timing, and content, enabling marketing and sales teams to optimize interactions with prescribing physicians
- Field Orchestrator: Real-time, this system delivers intelligence-driven recommendations to field teams, guiding personalized HCP interactions and aligning execution with AI insights for better decision-making
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Aktana
Qualtrax
HQ: United States
Website
- Description: Provider of intranet-based quality and document control solutions supporting regulatory requirements in regulated industries. Offerings include Ideagen Quality Management for document control, workflow automation, and risk management, and specialized Food & Beverage editions focused on supplier management, risk assessment, and compliance with food safety standards. Based in Christiansburg, Virginia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qualtrax company profile →
Kayentis
HQ: France
Website
- Description: Provider of eCOA and Decentralized Clinical Trial solutions that streamline clinical trial data collection and quality for pharma, biotech, and CROs. Offers Clin'form platform, app, web portal, and Connect for at-home/on-site capture, multi-mode entry, real-time monitoring, interoperability with EDC/CDMS, and integration with medical devices and wearables, plus project and data management services. Active since 2005 across phases I–IV and 200+ indications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kayentis company profile →
Parabricks
HQ: United States
Website
- Description: Provider of high-performance genomic analysis that can analyze a whole human genome in under an hour, compared to days, using state-of-the-art GPU acceleration and machine learning. Enables users to significantly increase throughput and supports personalized treatment based on genomic variations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parabricks company profile →
InfoChem
HQ: Germany
Website
- Description: Provider of software solutions for chemical information, focusing on the production and marketing of new products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InfoChem company profile →
SDI Health
HQ: United States
Website
- Description: Provider of healthcare market insight and analytics services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SDI Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Aktana
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Aktana
2.2 - Growth funds investing in similar companies to Aktana
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Aktana
4.2 - Public trading comparable groups for Aktana
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →